ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 650599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 650599; 2) Community: the network communities that were significantly associated with the response to NSC 650599; 3) Molecule: the relationships between components within communities and NSC 650599; 4) MDR: the compounds that were significantly associated with the NSC 650599.

NSC Compound Enrichment Correlation
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.000374267341249427 0.40520731
NSC 24500 2,6-Dimethoxy-p-benzoquinone 0.000374267341249427 0.49717972
NSC 606985 Camptothecin Derivative 0.000374267341249427 0.20824568
NSC 618939 Camptothecin Derivative 0.000374267341249427 0.33353847
NSC 371488 9-(3,4-dichlorophenyl)-2,7-bis((dimethylamino)methyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, dihydrochloride 0.000395532514722381 0.36150269
NSC 402590 Null 0.000395532514722381 0.59462018
NSC 624474 Null 0.000395532514722381 -0.29697869
NSC 632882 Dicarbonyl[1-(4-cyanaphenyl-NC-azomethyine)- naphthaline-2-olato(O1,N1)]iridium(I) 0.000395532514722381 0.41542195
NSC 679716 1H-Pyrazole-3-carboxylic acid, 5-benzoyl-4,5-dihydro- 4-phenyl-, ethyl ester 0.000395532514722381 0.41107777
NSC 702378 Null 0.000395532514722381 0.53353848
Total:116  Current:4    [First] [Prev] [Next] [Last]